Sponsored By

P&G Takes on Merck’s Consumer Health Division for $4.2B

April 20, 2018

2 Min Read
P&G Takes on Merck’s Consumer Health Division for $4.2B
Image courtesy of P&G

Seeking to expand its position in the over-the-counter (OTC) health products, the Procter & Gamble Company (R&G) signed an agreement with Merck to acquire the German firm’s Consumer Health division, Cincinnati, OH-based P&G announced in a press release Thursday.

“The Consumer Health business of Merck KGaA, Darmstadt, Germany, brings a strong set of brands, products, and capabilities, and provides and attractive and complementary footprint to further fuel growth as we continue to grow our existing leading brands,” Steve Bishop, group president of Global Health Care at P&G, in a statement.

Operating in 44 countries and offering more than 900 products, Merck’s Consumer Health division offers a OTC products for a variety of ailments including colds, headaches and pain. The division’s brands like Femibion and Seven Seas have a strong presence in Latin America, Asia, and Europe.

P&G said the acquisition provide a range of treatment areas not presently covered by the company’s offerings. In turn, the American company said it will increase the unit’s geographic presence and strengthen its existing positions in the world’s top OTC markets.

“This acquisition helps is continue to drive sales and profit growth for P&G by providing the capabilities and portfolio scale we need to operate a winning global OTC business on our own, without the aid of a health care partner,” said Tom Finn, president of P&G Global Personal Health Care, in the release.

The transaction is expected to close during the 2018-9 fiscal year pending regulatory clearances and other closing conditions. 

Click here for information about the upcoming International Powder & Bulk Solids Conference/Exhibition

For more news headlines, articles, and equipment reviews, visit our Equipment Zones

Sign up for the Powder & Bulk Solids Weekly newsletter.

You May Also Like